Myelocystocele

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:268813Q05.9
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Myelocystocele is a rare form of closed (skin-covered) spinal dysraphism, classified as a type of neural tube defect. It is characterized by a cystic dilation of the central canal of the spinal cord that herniates through a posterior spina bifida defect, forming a fluid-filled sac covered by skin. Myelocystocele most commonly occurs in the lumbosacral or terminal region of the spine and is sometimes referred to as terminal myelocystocele. The condition is typically detected at birth as a visible skin-covered mass over the lower back. Unlike open neural tube defects such as myelomeningocele, the neural tissue in myelocystocele remains covered by skin, which may reduce the risk of infection but does not eliminate neurological complications. The condition primarily affects the nervous system, the musculoskeletal system, and the urogenital system. Key clinical features include lower limb weakness or motor deficits, neurogenic bladder dysfunction, bowel dysfunction, and tethered spinal cord. Myelocystocele is frequently associated with other congenital anomalies, particularly those involving the genitourinary tract, anorectal malformations, and sacral bony abnormalities. It may occur as part of a broader spectrum of caudal anomalies. Some cases are associated with cloacal exstrophy or the OEIS complex (omphalocele, exstrophy, imperforate anus, spinal defects). Diagnosis is typically made through prenatal ultrasound or postnatal MRI imaging, which reveals the characteristic cystic expansion of the terminal spinal cord. Treatment is primarily surgical, involving neurosurgical repair to untether the spinal cord, drain the cyst, and reconstruct the dural and soft tissue layers. Early surgical intervention is generally recommended to prevent progressive neurological deterioration. Long-term management often requires a multidisciplinary approach including urology, orthopedics, and rehabilitation to address bladder dysfunction, mobility issues, and other associated anomalies. Prognosis varies depending on the severity of the defect and associated malformations, but many patients retain some degree of neurological function given the closed nature of the lesion.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Myelocystocele.

View clinical trials →

No actively recruiting trials found for Myelocystocele at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Myelocystocele community →

No specialists are currently listed for Myelocystocele.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Myelocystocele.

Search all travel grants →NORD Financial Assistance ↗

Community

Open MyelocystoceleForum →

No community posts yet. Be the first to share your experience with Myelocystocele.

Start the conversation →

Latest news about Myelocystocele

No recent news articles for Myelocystocele.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Myelocystocele

What is Myelocystocele?

Myelocystocele is a rare form of closed (skin-covered) spinal dysraphism, classified as a type of neural tube defect. It is characterized by a cystic dilation of the central canal of the spinal cord that herniates through a posterior spina bifida defect, forming a fluid-filled sac covered by skin. Myelocystocele most commonly occurs in the lumbosacral or terminal region of the spine and is sometimes referred to as terminal myelocystocele. The condition is typically detected at birth as a visible skin-covered mass over the lower back. Unlike open neural tube defects such as myelomeningocele, th

How is Myelocystocele inherited?

Myelocystocele follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Myelocystocele typically begin?

Typical onset of Myelocystocele is neonatal. Age of onset can vary across affected individuals.